share_log

Adaptimmune Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bertrand William C JR

SEC announcement ·  Jan 17 13:00
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.